1. Home
  2. ENVA vs CPRX Comparison

ENVA vs CPRX Comparison

Compare ENVA & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Enova International Inc.

ENVA

Enova International Inc.

HOLD

Current Price

$134.24

Market Cap

3.7B

Sector

Finance

ML Signal

HOLD

Logo Catalyst Pharmaceuticals Inc.

CPRX

Catalyst Pharmaceuticals Inc.

HOLD

Current Price

$23.28

Market Cap

3.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ENVA
CPRX
Founded
2011
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.7B
3.0B
IPO Year
2011
2006

Fundamental Metrics

Financial Performance
Metric
ENVA
CPRX
Price
$134.24
$23.28
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
1
Target Price
$173.00
$35.00
AVG Volume (30 Days)
238.6K
1.1M
Earning Date
04-28-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
55.05
28.24
EPS
11.52
1.68
Revenue
$3,151,653,000.00
$119,072,803.00
Revenue This Year
$149.91
$8.00
Revenue Next Year
$15.38
$9.77
P/E Ratio
$11.65
$13.83
Revenue Growth
18.58
16.39
52 Week Low
$79.41
$19.05
52 Week High
$176.68
$26.56

Technical Indicators

Market Signals
Indicator
ENVA
CPRX
Relative Strength Index (RSI) 37.40 42.88
Support Level $115.35 $22.46
Resistance Level $149.49 $24.86
Average True Range (ATR) 5.46 0.96
MACD -0.32 -0.13
Stochastic Oscillator 10.71 32.59

Price Performance

Historical Comparison
ENVA
CPRX

About ENVA Enova International Inc.

Enova International Inc provides online financial services, including short-term consumer loans, line of credit accounts, and installment loans to customers mainly in the United States and and Brazil. Consumers apply for credit online, the company's technology platforms process the applications, and transactions are completed quickly and efficiently. Its customers are predominantly retail consumers and small businesses. Enova markets its financing products under the names CashNetUSA, NetCredit, OnDeck, Headway Capital, and Simplic. The company also operates a money transfer platform under the name Pangea. Geographically, the company generates a majority of its revenue from its business in the United States and the rest from other international countries.

About CPRX Catalyst Pharmaceuticals Inc.

Catalyst Pharmaceuticals Inc is a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing, and commercializing novel high-quality medicines for patients living with rare and difficult to treat diseases. The Company sells three commercial stage drug products, FIRDAPSE (amifampridine), AGAMREE (vamorolone), and FYCOMPA (perampanel). The Company is currently seeking to further expand its product portfolio, with a focus on acquiring the rights to immediately and near-term accretive assets to treat rare (orphan) diseases across therapeutic areas, including clinical-stage opportunities with established proof of concept.

Share on Social Networks: